Cargando…
Characterization and Short-Term Outcome of Potential Celiac Disease in Children
Background and Objectives: Potential Celiac Disease (PCD) is defined by positive celiac serology without villous atrophy. We aimed to describe the short-term outcome of pediatric PCD while consuming a gluten-containing diet (GCD). Materials and Methods: Retrospective analysis of pediatric PCD patien...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383287/ https://www.ncbi.nlm.nih.gov/pubmed/37511994 http://dx.doi.org/10.3390/medicina59071182 |
_version_ | 1785080871958609920 |
---|---|
author | Kori, Michal Topf-Olivestone, Chani Rinawi, Firas Lev-Tzion, Raffi Ziv-Sokolovskaya, Nadya Lapidot Alon, Noy Guz-Mark, Anat Shamir, Raanan |
author_facet | Kori, Michal Topf-Olivestone, Chani Rinawi, Firas Lev-Tzion, Raffi Ziv-Sokolovskaya, Nadya Lapidot Alon, Noy Guz-Mark, Anat Shamir, Raanan |
author_sort | Kori, Michal |
collection | PubMed |
description | Background and Objectives: Potential Celiac Disease (PCD) is defined by positive celiac serology without villous atrophy. We aimed to describe the short-term outcome of pediatric PCD while consuming a gluten-containing diet (GCD). Materials and Methods: Retrospective analysis of pediatric PCD patients continuing GCD, between December 2018–January 2022. Baseline demographics, celiac serology and duodenal biopsy results were reviewed. Follow-up data included repeated serology and biopsy results when performed. Minimum follow-up was 12 months unless celiac disease (CeD) was diagnosed earlier. Results: PCD was diagnosed in 90 children (71% females) with a mean age of 7.2 (range 1.8–16.5) years. Baseline anti-tissue transglutaminase (TTG) levels were above 10 times the upper limit of normal (ULN) in 17/90 (18.9%), 3–10 × ULN in 56/90 (62.2%) and 1–3 × ULN in 17/90 (18.9%). During follow-up, the mean time was 17.6 (range 5–35) months, TTG normalized in 34/90 (37.8%), was stable in 48/90 (53.3%), and increased or remained >10 × ULN in 8/90 (8.9%). In 20/90 (22.2%) patients, a repeat endoscopy was performed, leading to CeD diagnosis in 12/20 (60%). Thus, at the end of follow-up, CeD was diagnosed in 12/90 (13.3%). In patients with TTG >10 × ULN at diagnosis, TTG normalized in 5/17, decreased to 3–10 × ULN in 8/17, and remained above 10 × ULN in 4/17. Conclusions: During the short-term follow-up of pediatric PCD patients, less than 15% progressed to CeD. A third had normalized TTG levels, including children with TTG >10 × ULN, indicating the need for periodic serological and histological follow-up among PCD patients. |
format | Online Article Text |
id | pubmed-10383287 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103832872023-07-30 Characterization and Short-Term Outcome of Potential Celiac Disease in Children Kori, Michal Topf-Olivestone, Chani Rinawi, Firas Lev-Tzion, Raffi Ziv-Sokolovskaya, Nadya Lapidot Alon, Noy Guz-Mark, Anat Shamir, Raanan Medicina (Kaunas) Article Background and Objectives: Potential Celiac Disease (PCD) is defined by positive celiac serology without villous atrophy. We aimed to describe the short-term outcome of pediatric PCD while consuming a gluten-containing diet (GCD). Materials and Methods: Retrospective analysis of pediatric PCD patients continuing GCD, between December 2018–January 2022. Baseline demographics, celiac serology and duodenal biopsy results were reviewed. Follow-up data included repeated serology and biopsy results when performed. Minimum follow-up was 12 months unless celiac disease (CeD) was diagnosed earlier. Results: PCD was diagnosed in 90 children (71% females) with a mean age of 7.2 (range 1.8–16.5) years. Baseline anti-tissue transglutaminase (TTG) levels were above 10 times the upper limit of normal (ULN) in 17/90 (18.9%), 3–10 × ULN in 56/90 (62.2%) and 1–3 × ULN in 17/90 (18.9%). During follow-up, the mean time was 17.6 (range 5–35) months, TTG normalized in 34/90 (37.8%), was stable in 48/90 (53.3%), and increased or remained >10 × ULN in 8/90 (8.9%). In 20/90 (22.2%) patients, a repeat endoscopy was performed, leading to CeD diagnosis in 12/20 (60%). Thus, at the end of follow-up, CeD was diagnosed in 12/90 (13.3%). In patients with TTG >10 × ULN at diagnosis, TTG normalized in 5/17, decreased to 3–10 × ULN in 8/17, and remained above 10 × ULN in 4/17. Conclusions: During the short-term follow-up of pediatric PCD patients, less than 15% progressed to CeD. A third had normalized TTG levels, including children with TTG >10 × ULN, indicating the need for periodic serological and histological follow-up among PCD patients. MDPI 2023-06-21 /pmc/articles/PMC10383287/ /pubmed/37511994 http://dx.doi.org/10.3390/medicina59071182 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kori, Michal Topf-Olivestone, Chani Rinawi, Firas Lev-Tzion, Raffi Ziv-Sokolovskaya, Nadya Lapidot Alon, Noy Guz-Mark, Anat Shamir, Raanan Characterization and Short-Term Outcome of Potential Celiac Disease in Children |
title | Characterization and Short-Term Outcome of Potential Celiac Disease in Children |
title_full | Characterization and Short-Term Outcome of Potential Celiac Disease in Children |
title_fullStr | Characterization and Short-Term Outcome of Potential Celiac Disease in Children |
title_full_unstemmed | Characterization and Short-Term Outcome of Potential Celiac Disease in Children |
title_short | Characterization and Short-Term Outcome of Potential Celiac Disease in Children |
title_sort | characterization and short-term outcome of potential celiac disease in children |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383287/ https://www.ncbi.nlm.nih.gov/pubmed/37511994 http://dx.doi.org/10.3390/medicina59071182 |
work_keys_str_mv | AT korimichal characterizationandshorttermoutcomeofpotentialceliacdiseaseinchildren AT topfolivestonechani characterizationandshorttermoutcomeofpotentialceliacdiseaseinchildren AT rinawifiras characterizationandshorttermoutcomeofpotentialceliacdiseaseinchildren AT levtzionraffi characterizationandshorttermoutcomeofpotentialceliacdiseaseinchildren AT zivsokolovskayanadya characterizationandshorttermoutcomeofpotentialceliacdiseaseinchildren AT lapidotalonnoy characterizationandshorttermoutcomeofpotentialceliacdiseaseinchildren AT guzmarkanat characterizationandshorttermoutcomeofpotentialceliacdiseaseinchildren AT shamirraanan characterizationandshorttermoutcomeofpotentialceliacdiseaseinchildren |